What is ZS's health score?

Zscaler, Inc. (ZS) has a TradeApes health score of 55 out of 100, rated Mixed. This composite score evaluates financial strength, operating trends, valuation, capital allocation, and risk factors.

What is ZS's estimated fair value?

Based on our 5-year discounted cash flow model, Zscaler, Inc.'s estimated fair value is $41.46 per share, representing a -70.3% downside from the current price. This is a model estimate, not a price target or investment recommendation.

Is ZS undervalued or overvalued?

Our model currently rates ZS as Overvalued. This assessment combines health metrics, valuation multiples, and market sentiment. Individual investors should conduct their own due diligence.

Crunching the numbers for ZS... Refresh in a moment for the full analysis.

Zscaler, Inc. (ZS)

Technology Overvalued low mixed

$139.73

Updated: 2026-05-30

TradeApes Score

Financial Strength

55 Mixed

Operating Trend

73 Healthy

Relative Value

55 Mixed

Capital Allocation

25 Stressed

Risk

50 Mixed

Est. Fair Value $41.46

DCF Upside -70.3%

Sector Rank #280 of 7745

Key Findings

+ Strong revenue growth — sales up more than 20% year over year

Unlock Full Report →

− Excessive stock comp — SBC above 15% of revenue, wealth transfer to employees

Unlock Full Report →

Create an account for unlimited access

TradeApes provides financial data, analytics, and research tools. TradeApes is not a registered investment adviser, broker-dealer, or tax advisor. The information presented is for educational and informational purposes only and does not constitute investment, financial, or tax advice.

11 sector-leading stocks delivered to your inbox every Sunday. Free.

No spam. Unsubscribe anytime.